APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Maternal Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Maternal Mental Health Market Analysis and Forecast 2026-2032

Report ID 17418370024 March 2026194 pages

Choose your research edition.

Industry ResearchMaternal Mental Health Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Maternal Mental Health Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Maternal Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Maternal Mental Health Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Maternal Mental Health Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Maternal Mental Health market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Maternal Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Maternal Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Maternal Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Maternal Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Maternal Mental Health include Lipocine, Pfizer, Viatris, Bold Health, Glaxo Smith Kline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc. and Bausch Health Companies Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Maternal Mental Health, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Maternal Mental Health, also provides the revenue of main regions and countries. Of the upcoming market potential for Maternal Mental Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Maternal Mental Health revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Maternal Mental Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Maternal Mental Health revenue, projected growth trends, production technology, application and end-user industry.

Maternal Mental Health Segment by Company

Lipocine

Pfizer

Viatris

Bold Health

Glaxo Smith Kline Inc.

Alembic Pharmaceuticals Limited

Mallinckrodt

Sage Therapeutics, Inc.

Bausch Health Companies Inc.

Magellan Health

Maternal Mental Health Segment by Type

Antidepressants

Interpersonal Psychotherapy

Cognitive Behavioural Therapy

Others

Maternal Mental Health Segment by Application

Clinics

Hospitals

Others

Maternal Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Maternal Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Maternal Mental Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Maternal Mental Health company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maternal Mental Health revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Maternal Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antidepressants Major Player Table 3. Interpersonal Psychotherapy Major Player Table 4. Cognitive Behavioural Therapy Major Player Table 5. Others Major Player Table 6. Global Maternal Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinics Major Player Table 8. Hospitals Major Player Table 9. Others Major Player Table 10. Maternal Mental Health Industry Trends Table 11. Maternal Mental Health Industry Drivers Table 12. Maternal Mental Health Industry Opportunities and Challenges Table 13. Maternal Mental Health Industry Restraints Table 14. Global Maternal Mental Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Maternal Mental Health Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Maternal Mental Health Market Share by Region (2021-2026) Table 17. Global Maternal Mental Health Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Maternal Mental Health Market Share by Region (2027-2032) Table 19. Global Maternal Mental Health Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Maternal Mental Health Revenue Market Share by Players (2021-2026) Table 21. Global Maternal Mental Health Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Maternal Mental Health Key Players Headquarters & Area Served Table 23. Global Maternal Mental Health Players, Product Type & Application Table 24. Global Maternal Mental Health Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Maternal Mental Health by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Maternal Mental Health Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Maternal Mental Health Revenue Market Share by Type (2021-2026) Table 31. Global Maternal Mental Health Revenue Market Share by Type (2027-2032) Table 32. Global Maternal Mental Health Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Maternal Mental Health Revenue Market Share by Application (2021-2026) Table 36. Global Maternal Mental Health Revenue Market Share by Application (2027-2032) Table 37. Lipocine Company Information Table 38. Lipocine Business Overview Table 39. Lipocine Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Lipocine Maternal Mental Health Product Portfolio Table 41. Lipocine Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Maternal Mental Health Product Portfolio Table 46. Pfizer Recent Development Table 47. Viatris Company Information Table 48. Viatris Business Overview Table 49. Viatris Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Viatris Maternal Mental Health Product Portfolio Table 51. Viatris Recent Development Table 52. Bold Health Company Information Table 53. Bold Health Business Overview Table 54. Bold Health Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bold Health Maternal Mental Health Product Portfolio Table 56. Bold Health Recent Development Table 57. Glaxo Smith Kline Inc. Company Information Table 58. Glaxo Smith Kline Inc. Business Overview Table 59. Glaxo Smith Kline Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio Table 61. Glaxo Smith Kline Inc. Recent Development Table 62. Alembic Pharmaceuticals Limited Company Information Table 63. Alembic Pharmaceuticals Limited Business Overview Table 64. Alembic Pharmaceuticals Limited Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio Table 66. Alembic Pharmaceuticals Limited Recent Development Table 67. Mallinckrodt Company Information Table 68. Mallinckrodt Business Overview Table 69. Mallinckrodt Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Mallinckrodt Maternal Mental Health Product Portfolio Table 71. Mallinckrodt Recent Development Table 72. Sage Therapeutics, Inc. Company Information Table 73. Sage Therapeutics, Inc. Business Overview Table 74. Sage Therapeutics, Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio Table 76. Sage Therapeutics, Inc. Recent Development Table 77. Bausch Health Companies Inc. Company Information Table 78. Bausch Health Companies Inc. Business Overview Table 79. Bausch Health Companies Inc. Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Bausch Health Companies Inc. Maternal Mental Health Product Portfolio Table 81. Bausch Health Companies Inc. Recent Development Table 82. Magellan Health Company Information Table 83. Magellan Health Business Overview Table 84. Magellan Health Maternal Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Magellan Health Maternal Mental Health Product Portfolio Table 86. Magellan Health Recent Development Table 87. North America Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Maternal Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Maternal Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Maternal Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Maternal Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 101. China Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 102. China Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 103. China Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 104. China Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Maternal Mental Health Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Maternal Mental Health Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Maternal Mental Health Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Maternal Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Maternal Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Maternal Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Maternal Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Maternal Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Maternal Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Maternal Mental Health Image Figure 2. Global Maternal Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Maternal Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antidepressants Image Figure 5. Interpersonal Psychotherapy Image Figure 6. Cognitive Behavioural Therapy Image Figure 7. Others Image Figure 8. Global Maternal Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Maternal Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinics Image Figure 11. Hospitals Image Figure 12. Others Image Figure 13. Global Maternal Mental Health Market Size (US$ Million) & (2021-2032) Figure 14. Global Maternal Mental Health Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Maternal Mental Health Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Maternal Mental Health Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Maternal Mental Health Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Maternal Mental Health Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Maternal Mental Health Revenue Market Share by Type (2021-2032) Figure 21. Global Maternal Mental Health Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Maternal Mental Health Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Maternal Mental Health Revenue Market Share by Application (2021-2032) Figure 24. North America Maternal Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Maternal Mental Health Revenue Share by Type (2021-2032) Figure 26. North America Maternal Mental Health Revenue Share by Application (2021-2032) Figure 27. North America Maternal Mental Health Revenue Share by Country (2021-2032) Figure 28. United States Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Maternal Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Maternal Mental Health Revenue Share by Type (2021-2032) Figure 33. Europe Maternal Mental Health Revenue Share by Application (2021-2032) Figure 34. Europe Maternal Mental Health Revenue Share by Country (2021-2032) Figure 35. Germany Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Maternal Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Maternal Mental Health Revenue Share by Type (2021-2032) Figure 45. China Maternal Mental Health Revenue Share by Application (2021-2032) Figure 46. Asia Maternal Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Maternal Mental Health Revenue Share by Type (2021-2032) Figure 48. Asia Maternal Mental Health Revenue Share by Application (2021-2032) Figure 49. Asia Maternal Mental Health Revenue Share by Region (2021-2032) Figure 50. Japan Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Maternal Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Maternal Mental Health Revenue Share by Type (2021-2032) Figure 58. SAMEA Maternal Mental Health Revenue Share by Application (2021-2032) Figure 59. SAMEA Maternal Mental Health Revenue Share by Country (2021-2032) Figure 60. Brazil Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Maternal Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antidepressants
  • Interpersonal Psychotherapy
  • Cognitive Behavioural Therapy
  • Others
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Lipocine
  • Pfizer
  • Viatris
  • Bold Health
  • Glaxo Smith Kline Inc.
  • Alembic Pharmaceuticals Limited
  • Mallinckrodt
  • Sage Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Magellan Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Maternal Mental Health Market by Type
  3. 1.2.1 Global Maternal Mental Health Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antidepressants
  5. 1.2.3 Interpersonal Psychotherapy
  6. 1.2.4 Cognitive Behavioural Therapy
  7. 1.2.5 Others
  8. 1.3 Maternal Mental Health Market by Application
  9. 1.3.1 Global Maternal Mental Health Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinics
  11. 1.3.3 Hospitals
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Maternal Mental Health Market Dynamics
  1. 2.1 Maternal Mental Health Industry Trends
  2. 2.2 Maternal Mental Health Industry Drivers
  3. 2.3 Maternal Mental Health Industry Opportunities and Challenges
  4. 2.4 Maternal Mental Health Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Maternal Mental Health Market Perspective (2021-2032)
  2. 3.2 Global Maternal Mental Health Growth Trends by Region
  3. 3.2.1 Global Maternal Mental Health Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Maternal Mental Health Market Size by Region (2021-2026)
  5. 3.2.3 Global Maternal Mental Health Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Maternal Mental Health Revenue by Players
  2. 4.1.1 Global Maternal Mental Health Revenue by Players (2021-2026)
  3. 4.1.2 Global Maternal Mental Health Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Maternal Mental Health Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Maternal Mental Health Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Maternal Mental Health Key Players Headquarters & Area Served
  7. 4.4 Global Maternal Mental Health Players, Product Type & Application
  8. 4.5 Global Maternal Mental Health Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Maternal Mental Health Market CR5 and HHI
  11. 4.6.3 2025 Maternal Mental Health Tier 1, Tier 2, and Tier 3
5 Maternal Mental Health Market Size by Type
  1. 5.1 Global Maternal Mental Health Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Maternal Mental Health Revenue by Type (2021-2032)
  3. 5.3 Global Maternal Mental Health Revenue Market Share by Type (2021-2032)
6 Maternal Mental Health Market Size by Application
  1. 6.1 Global Maternal Mental Health Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Maternal Mental Health Revenue by Application (2021-2032)
  3. 6.3 Global Maternal Mental Health Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lipocine
  2. 7.1.1 Lipocine Company Information
  3. 7.1.2 Lipocine Business Overview
  4. 7.1.3 Lipocine Maternal Mental Health Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lipocine Maternal Mental Health Product Portfolio
  6. 7.1.5 Lipocine Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Maternal Mental Health Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Maternal Mental Health Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Viatris
  14. 7.3.1 Viatris Company Information
  15. 7.3.2 Viatris Business Overview
  16. 7.3.3 Viatris Maternal Mental Health Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Viatris Maternal Mental Health Product Portfolio
  18. 7.3.5 Viatris Recent Developments
  19. 7.4 Bold Health
  20. 7.4.1 Bold Health Company Information
  21. 7.4.2 Bold Health Business Overview
  22. 7.4.3 Bold Health Maternal Mental Health Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bold Health Maternal Mental Health Product Portfolio
  24. 7.4.5 Bold Health Recent Developments
  25. 7.5 Glaxo Smith Kline Inc.
  26. 7.5.1 Glaxo Smith Kline Inc. Company Information
  27. 7.5.2 Glaxo Smith Kline Inc. Business Overview
  28. 7.5.3 Glaxo Smith Kline Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio
  30. 7.5.5 Glaxo Smith Kline Inc. Recent Developments
  31. 7.6 Alembic Pharmaceuticals Limited
  32. 7.6.1 Alembic Pharmaceuticals Limited Company Information
  33. 7.6.2 Alembic Pharmaceuticals Limited Business Overview
  34. 7.6.3 Alembic Pharmaceuticals Limited Maternal Mental Health Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio
  36. 7.6.5 Alembic Pharmaceuticals Limited Recent Developments
  37. 7.7 Mallinckrodt
  38. 7.7.1 Mallinckrodt Company Information
  39. 7.7.2 Mallinckrodt Business Overview
  40. 7.7.3 Mallinckrodt Maternal Mental Health Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mallinckrodt Maternal Mental Health Product Portfolio
  42. 7.7.5 Mallinckrodt Recent Developments
  43. 7.8 Sage Therapeutics, Inc.
  44. 7.8.1 Sage Therapeutics, Inc. Company Information
  45. 7.8.2 Sage Therapeutics, Inc. Business Overview
  46. 7.8.3 Sage Therapeutics, Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio
  48. 7.8.5 Sage Therapeutics, Inc. Recent Developments
  49. 7.9 Bausch Health Companies Inc.
  50. 7.9.1 Bausch Health Companies Inc. Company Information
  51. 7.9.2 Bausch Health Companies Inc. Business Overview
  52. 7.9.3 Bausch Health Companies Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bausch Health Companies Inc. Maternal Mental Health Product Portfolio
  54. 7.9.5 Bausch Health Companies Inc. Recent Developments
  55. 7.10 Magellan Health
  56. 7.10.1 Magellan Health Company Information
  57. 7.10.2 Magellan Health Business Overview
  58. 7.10.3 Magellan Health Maternal Mental Health Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Magellan Health Maternal Mental Health Product Portfolio
  60. 7.10.5 Magellan Health Recent Developments
8 North America
  1. 8.1 North America Maternal Mental Health Revenue (2021-2032)
  2. 8.2 North America Maternal Mental Health Revenue by Type (2021-2032)
  3. 8.2.1 North America Maternal Mental Health Revenue by Type (2021-2026)
  4. 8.2.2 North America Maternal Mental Health Revenue by Type (2027-2032)
  5. 8.3 North America Maternal Mental Health Revenue Share by Type (2021-2032)
  6. 8.4 North America Maternal Mental Health Revenue by Application (2021-2032)
  7. 8.4.1 North America Maternal Mental Health Revenue by Application (2021-2026)
  8. 8.4.2 North America Maternal Mental Health Revenue by Application (2027-2032)
  9. 8.5 North America Maternal Mental Health Revenue Share by Application (2021-2032)
  10. 8.6 North America Maternal Mental Health Revenue by Country
  11. 8.6.1 North America Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Maternal Mental Health Revenue by Country (2021-2026)
  13. 8.6.3 North America Maternal Mental Health Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Maternal Mental Health Revenue (2021-2032)
  2. 9.2 Europe Maternal Mental Health Revenue by Type (2021-2032)
  3. 9.2.1 Europe Maternal Mental Health Revenue by Type (2021-2026)
  4. 9.2.2 Europe Maternal Mental Health Revenue by Type (2027-2032)
  5. 9.3 Europe Maternal Mental Health Revenue Share by Type (2021-2032)
  6. 9.4 Europe Maternal Mental Health Revenue by Application (2021-2032)
  7. 9.4.1 Europe Maternal Mental Health Revenue by Application (2021-2026)
  8. 9.4.2 Europe Maternal Mental Health Revenue by Application (2027-2032)
  9. 9.5 Europe Maternal Mental Health Revenue Share by Application (2021-2032)
  10. 9.6 Europe Maternal Mental Health Revenue by Country
  11. 9.6.1 Europe Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Maternal Mental Health Revenue by Country (2021-2026)
  13. 9.6.3 Europe Maternal Mental Health Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Maternal Mental Health Revenue (2021-2032)
  2. 10.2 China Maternal Mental Health Revenue by Type (2021-2032)
  3. 10.2.1 China Maternal Mental Health Revenue by Type (2021-2026)
  4. 10.2.2 China Maternal Mental Health Revenue by Type (2027-2032)
  5. 10.3 China Maternal Mental Health Revenue Share by Type (2021-2032)
  6. 10.4 China Maternal Mental Health Revenue by Application (2021-2032)
  7. 10.4.1 China Maternal Mental Health Revenue by Application (2021-2026)
  8. 10.4.2 China Maternal Mental Health Revenue by Application (2027-2032)
  9. 10.5 China Maternal Mental Health Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Maternal Mental Health Revenue (2021-2032)
  2. 11.2 Asia Maternal Mental Health Revenue by Type (2021-2032)
  3. 11.2.1 Asia Maternal Mental Health Revenue by Type (2021-2026)
  4. 11.2.2 Asia Maternal Mental Health Revenue by Type (2027-2032)
  5. 11.3 Asia Maternal Mental Health Revenue Share by Type (2021-2032)
  6. 11.4 Asia Maternal Mental Health Revenue by Application (2021-2032)
  7. 11.4.1 Asia Maternal Mental Health Revenue by Application (2021-2026)
  8. 11.4.2 Asia Maternal Mental Health Revenue by Application (2027-2032)
  9. 11.5 Asia Maternal Mental Health Revenue Share by Application (2021-2032)
  10. 11.6 Asia Maternal Mental Health Revenue by Country
  11. 11.6.1 Asia Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Maternal Mental Health Revenue by Country (2021-2026)
  13. 11.6.3 Asia Maternal Mental Health Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Maternal Mental Health Revenue (2021-2032)
  2. 12.2 SAMEA Maternal Mental Health Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Maternal Mental Health Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Maternal Mental Health Revenue by Type (2027-2032)
  5. 12.3 SAMEA Maternal Mental Health Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Maternal Mental Health Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Maternal Mental Health Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Maternal Mental Health Revenue by Application (2027-2032)
  9. 12.5 SAMEA Maternal Mental Health Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Maternal Mental Health Revenue by Country
  11. 12.6.1 SAMEA Maternal Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Maternal Mental Health Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Maternal Mental Health Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst